WCG Appoints Sam Srivastava as Chief Executive Officer3

WCG Appoints Sam Srivastava as Chief Executive Officer3
share Share

WCG, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research announced it has appointed Sam Srivastava as Chief Executive Officer. Srivastava joins WCG from NeueHealth, a tech enabled risk bearing care delivery company, where he also served as CEO. He succeeds Dr. Donald Deieso, upon his retirement.


In his role as CEO, Srivastava will oversee all WCG global operations. In a career spanning 30 years, Srivastava has been a recognized thought leader and strategist in the healthcare industry. Prior to NeueHealth, he held executive leadership roles for companies including Bright Health, Magellan Healthcare, Cigna, and United Health Group.


"Joining WCG at this pivotal moment in their growth and transformation is an honor," remarked Srivastava. "The clinical trials industry is in need of disruption, and WCG is the only company in the market with the solutions, data, technology, and expertise to make it happen. We are in a unique position to drive the advancement needed throughout the clinical trials ecosystem to enable the delivery of better healthcare. I'm excited to join this trailblazing team and lead this innovative strategy."


"As WCG continues to shape the clinical trials sector, I am excited that Sam, a recognized and respected industry leader with deep expertise and an exceptional track record, will be leading the WCG team. His unique perspectives and expertise in strategy, development, integration, and operations will drive deeper awareness and preference for WCG's differentiated solutions with our rapidly expanding network of customers and partners while also strengthening our market position," said Dr. Deieso.


Source: WCG

«« Monkeypox Spreads Around the World


The Nursing Workforce Needs Greater Investment »»

Published on : Wed, 18 May 2022



Related Articles

GeoBlue, the leader in high-tech, high-touch health insurance solutions for the globally mobile, announces the appointment of... Read more

– Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead... Read more

Experienced technology-driven innovator aims to position and  accelerate the company's first-of-its - kind surgical technology... Read more

WCG,clinical research,Sam Srivastava,Chief Executive Officer WCG, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research announced it has appointed Sam Srivastava as Chief Executive Officer.

No comment


Please login to leave a comment...